SBI Pharma (India) Financial Indicators Patterns

F0GBR06R8K -- India Fund  

INR 128.41  2.91  2.22%

We advise you to exercise SBI Pharma fundamental analysis to see if markets are today mispricing the fund. In other words you can harness it to find out if SBI Pharma Reg is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found seven available drivers for SBI Pharma Reg Gr which can be compared to its competition. Please use SBI Pharma Minimum Initial Investment to make a decision on weather SBI Pharma Reg is priced fairly. Use SBI Pharma to protect against small markets fluctuations. The fund experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of SBI Pharma to be traded at 123.27 in 30 days

SBI Pharma Company Summary

The scheme aims to provide the investors maximum growth opportunity through equity investment in stocks of Pharma Sector. SBI Pharma is traded on Bombay Stock Exchange in India.

SBI Pharma Cash Position Weight vs Equity Positions Weight

SBI Pharma Reg Gr is one of the top funds in cash position weight among similar funds. It is one of the top funds in equity positions weight among similar funds making about  17.25  of Equity Positions Weight per Cash Position Weight.

SBI Pharma Market Fundamentals

 Quote128.41
 Change(%) 2.22%
 Change2.91 
 Open131.32
 Low127.96
 High128.86
 Volume1.000
 ExchangeBSE

Distress Rating

SBI Pharma Financial Distress Probability

10% 
Chance of Financial Distress
SBI Pharma Reg Gr has less than 10 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
SBI Pharma Reg Gr is one of the top funds in net asset among similar funds. Total Asset Under Management (AUM) of Sector - Healthcare category is currently estimated at about 657.9 Million. SBI Pharma totals roughly 328.95 Million in net asset claiming about 50% of funds listed under Sector - Healthcare category.

Compare SBI Pharma

Compare SBI Pharma To Peers

SBI Pharma Opportunity Range

September 23, 2018 Opportunity Range

Additionally see Investing Opportunities. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.
Search macroaxis.com